Raymond James Financial Inc. Takes Position in Dyne Therapeutics, Inc. (NASDAQ:DYN)
MarketBeat
Raymond James Financial Inc. purchased a new stake in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 99,328 shares of the company's stock, valued at approximately $2,340,000. Raymond James Financial Inc.
NASDAQ:DYN